创新药概念股

Search documents
七成投资者看好三季度A股 市场乐观情绪进一步酝酿——上海证券报·个人投资者2025年第三季度调查报告
Shang Hai Zheng Quan Bao· 2025-08-04 18:52
郭晨凯 制图 | 请问您在2025年二季度的平均投资业绩是 | | | --- | --- | | 1). 持平 | 32% | | 2). 盈利10%以内 | 34% | | 3). 盈利10%-30% | 6% | | 4). 盈利30%及以上 | 8% | | 5). 亏损10%以内 | 15% | | 6). 亏损10%-30% | 3% | | 7). 亏损30%及以上 | 2% | (感谢申万宏源证券、东北证券相关营业部对本调查的支持。上图为部分调查结果) □ A 股三大指数在二季度探底回升呈"V"形走势,在行情回暖的背景下,48%的受访投资者表示在二季 度实现盈利 □ 伴随指数连续反弹,投资者持有的权益资产估值逐渐修复,其对未来证券账户的配置意愿也出现回升 □ 二季度,个人投资者延续对科技成长股的投资热情,对该板块的平均持仓水平高于其他板块。同时, 上游原材料的涨价潮推动投资者开始关注周期股 □ 七成投资者看涨三季度A股行情,较前一季度大幅增加12个百分点。同时,认为三季度港股市场将收 红的投资者占比也达到了57% ◎记者 汪友若 二季度大盘"V"形反弹 近五成投资者盈利 二季度,A股市场在4月 ...
A股收评:创业板指高开高走涨2.63%,苹果概念股午后持续走强
news flash· 2025-05-12 07:01
Market Performance - The three major A-share indices collectively rose today, with the Shanghai Composite Index up by 0.82%, the Shenzhen Component Index up by 1.72%, the ChiNext Index up by 2.63%, and the North Star 50 Index up by 2.89% [1] - The total market turnover reached 1.34 trillion yuan, an increase of 118.5 billion yuan compared to the previous day [1] - Over 4,100 stocks in the market experienced gains [1] Sector Performance - The military industry, robotics, Apple supply chain, rail transit equipment, photovoltaic equipment, and solid-state battery sectors saw the largest gains [1] - Conversely, the precious metals, agriculture, innovative pharmaceuticals, electricity, and beverage manufacturing sectors experienced declines [1] Notable Stocks - Military stocks surged again, with over 20 stocks hitting the daily limit, including Qifeng Precision, Kunshan Intelligent, AVIC Chengfei, Morningstar Aviation, and Aerospace Nanhu [1] - Stocks in the Apple supply chain rebounded collectively due to favorable news from US-China negotiations, with Blue Technology, Luxshare Precision, and GoerTek leading the gains [1] - The robotics sector was also active, with TOSYDA hitting the daily limit, and Efort rising over 10%, along with Sanfeng Intelligent, Yijiahe, and Estun following suit [1] - Innovative pharmaceutical stocks weakened, with Maiwei Biotech down over 10%, BeiGene down over 9%, and other companies like Shutai Pharmaceutical, Xinlitai, and Hengrui Medicine also declining [1] - Gold stocks underperformed, with Western Gold, Sichuan Gold, and Xiaocheng Technology among those with the largest declines [1]